Search Login Register

calpain inhibitors Summary

Description: bovine heart protein; MW 145,000; from many cells & tissues with MW 48,000-400,000 depending on tissue, species or isolation procedures

Also Known As: CANP-I; calcium dependent protease inhibitor; calcium-activated neutral protease inhibitor; calpain inhibitor; calpain inhibitor I

Networked: 282 relevant articles (33 outcomes, 33 trials/studies) for this Bio-Agent

Key Diseases for which calpain inhibitors is Relevant

  1. Anoxia (Hypoxia) : 5 outcomes 1 study in 21 results
  2. Ischemia : 4 outcomes 3 studies in 31 results
  3. Spinal Cord Injuries (Spinal Cord Injury) : 3 outcomes 4 studies in 13 results
  4. Brain Ischemia (Cerebral Ischemia) : 3 outcomes 1 study in 17 results
  5. Cataract (Cataracts) : 3 outcomes 1 study in 10 results
Show All >>

Drugs Related to calpain inhibitors

  1. Calpain
  2. calpain inhibitor III
  3. ((1S)- 1- ((((1S)- 1- benzyl- 3- cyclopropylamino- 2,3- di- oxopropyl)amino)carbonyl)- 3- methylbutyl)carbamic acid 5-methoxy-3-oxapentyl ester
  4. N- (4- fluorophenylsulfonyl)- L- valyl- L- leucinal
  5. calpeptin
  6. Calcium
  7. Cysteine Proteases (Cysteine Protease)
  8. Caspase 3 (Caspase-3)
  9. mu-calpain
  10. Proteasome Endopeptidase Complex (Proteasome)
Show All >>

Therapies Related to calpain inhibitors

  1. Lenses
  2. Catheters
  3. Immunomodulation
  4. Intensive Care (Surgical Intensive Care)
  5. Resuscitation
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.